Torrent Pharmaceuticals Limited (TORNTPHARM) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

Total Revenue Chart for Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited (TORNTPHARM) revenue for FY2026 was INR 139.8B, a 23.5% change from FY2025. Torrent Pharmaceuticals Limited's revenue grew from INR 5.5B in 2005 to INR 139.8B in 2026 (2452.2% over 21 years). Earnings per share grew from INR 19.62 in 2014 to INR 56.48 in 2025 (187.9%). Revenue compound annual growth rate: 5-year CAGR of 12.1%, 10-year CAGR of 7.9%, 20-year CAGR of 14.3%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.